Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator.

Primo J, Geelen P, Brugada J, Filho AL, Mont L, Wellens F, Valentino M, Brugada P.

J Am Coll Cardiol. 1998 Apr;31(5):1081-5.

PMID:
9562010
[PubMed - indexed for MEDLINE]
Free Article
2.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Epub 2008 Mar 31. Review.

PMID:
18384577
[PubMed - indexed for MEDLINE]
3.

Management of hypertrophic cardiomyopathy in children.

Seggewiss H, Rigopoulos A.

Paediatr Drugs. 2003;5(10):663-72. Review.

PMID:
14510624
[PubMed - indexed for MEDLINE]
4.

[Interventional treatment in hypertrophic cardiomyopathy].

Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.

Herz. 2005 Mar;30(2):102-10. Review. German.

PMID:
15875098
[PubMed - indexed for MEDLINE]
5.

Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.

Cotiga D, Ehlert F, Sherrid M.

Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:55-60. Review.

PMID:
17162272
[PubMed - indexed for MEDLINE]
Free Article
6.

[Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].

Pellnitz C, Geier C, Perrot A, Dietz R, Osterziel KJ, Haverkamp W.

Dtsch Med Wochenschr. 2005 May 6;130(18):1150-4. Review. German.

PMID:
15856398
[PubMed - indexed for MEDLINE]
7.

[Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].

Fauchère I, Duru F.

Praxis (Bern 1994). 2009 Aug 26;98(17):941-52. doi: 10.1024/1661-8157.98.17.941. Review. German.

PMID:
19711287
[PubMed - indexed for MEDLINE]
8.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
[PubMed - indexed for MEDLINE]
9.

Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy.

Maron BJ.

Curr Cardiol Rep. 2000 Nov;2(6):522-8. Review.

PMID:
11060579
[PubMed - indexed for MEDLINE]
10.

Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease.

Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, Scheld HH.

Am Heart J. 1994 Apr;127(4 Pt 2):1151-8. Review.

PMID:
8160595
[PubMed - indexed for MEDLINE]
11.

Sudden death and hypertrophic cardiomyopathy: a review.

Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.

Can J Cardiol. 2005 Apr;21(5):441-8. Review.

PMID:
15861263
[PubMed - indexed for MEDLINE]
12.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

PMID:
22821634
[PubMed - indexed for MEDLINE]
Free Article
13.

Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature.

Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, Cokkinos DV.

Int J Cardiol. 2005 Feb 28;98(3):395-401. Review.

PMID:
15708170
[PubMed - indexed for MEDLINE]
14.

Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy.

Freedman RA.

Curr Opin Cardiol. 2001 Jan;16(1):58-65. Review.

PMID:
11124720
[PubMed - indexed for MEDLINE]
15.

Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.

Ostman-Smith I.

Fundam Clin Pharmacol. 2010 Oct;24(5):637-52. doi: 10.1111/j.1472-8206.2010.00869.x. Epub 2010 Aug 19. Review.

PMID:
20727015
[PubMed - indexed for MEDLINE]
16.

Risks and challenges of implantable cardioverter-defibrillators in young adults.

Sherrid MV, Daubert JP.

Prog Cardiovasc Dis. 2008 Nov-Dec;51(3):237-63. doi: 10.1016/j.pcad.2008.10.001. Review.

PMID:
19026858
[PubMed - indexed for MEDLINE]
17.

Sudden death in hypertrophic cardiomyopathy.

Maron BJ.

J Cardiovasc Transl Res. 2009 Dec;2(4):368-80. doi: 10.1007/s12265-009-9147-0. Epub 2009 Nov 13. Review.

PMID:
20559995
[PubMed - indexed for MEDLINE]
18.

Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy.

Maron BJ.

Circ J. 2010 Nov;74(11):2271-82. Epub 2010 Oct 16. Review.

PMID:
20962423
[PubMed - indexed for MEDLINE]
Free Article
19.

Risk factors for systolic dysfunction and ventricular dilatation in hypertrophic cardiomyopathy.

Bingisser R, Candinas R, Schneider J, Hess OM.

Int J Cardiol. 1994 May;44(3):225-33. Review.

PMID:
8077068
[PubMed - indexed for MEDLINE]
20.

Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?

Östman-Smith I, Rossano JW, Shaddy RE.

Curr Opin Cardiol. 2013 Mar;28(2):130-8. doi: 10.1097/HCO.0b013e32835dd020. Review.

PMID:
23348710
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk